Improving ADC Quality & Manufacturing While Cutting Program Costs to Accelerate ADC Development to Patients

• Advancing ADC development through cost-effective solutions 
• Driving ADC success with flexible and high-quality solutions from preclinical to commercial development
• Ensuring right first-time-approved regulatory submission to save time and costs bringing ADCs to patients in need

Speakers:

Fabrizia Minandri

Technology Transfer Manager, Large Molecule ADCs Platform

BSP Pharmaceuticals S.p.A